Literature DB >> 560851

Preferential inhibition of the low Km aldehyde dehydrogenase activity by pargyline.

M E Lebsack, D R Petersen, A C Collins, A D Anderson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 560851     DOI： 10.1016/0006-2952(77)90060-0

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  4 in total

Review 1.  Post-translational modifications of mitochondrial aldehyde dehydrogenase and biomedical implications.

Authors:  Byoung-Joon Song; Mohamed A Abdelmegeed; Seong-Ho Yoo; Bong-Jo Kim; Sangmee A Jo; Inho Jo; Kwan-Hoon Moon
Journal:  J Proteomics       Date:  2011-05-15       Impact factor: 4.044

Review 2.  Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application.

Authors:  Vindhya Koppaka; David C Thompson; Ying Chen; Manuel Ellermann; Kyriacos C Nicolaou; Risto O Juvonen; Dennis Petersen; Richard A Deitrich; Thomas D Hurley; Vasilis Vasiliou
Journal:  Pharmacol Rev       Date:  2012-04-27       Impact factor: 25.468

3.  Inhibition of the low-Km mitochondrial aldehyde dehydrogenase by diethyl maleate and phorone in vivo and in vitro. Implications for formaldehyde metabolism.

Authors:  E Dicker; A I Cederbaum
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

4.  Effects of pargyline and diethyldithiocarbamate in vivo treatment on aldehyde dehydrogenase activities of submitochondrial fractions.

Authors:  S Nakanishi; H Yamazaki; K Nishiguchi; R Saladin
Journal:  Arch Toxicol       Date:  1980-12       Impact factor: 5.153
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.